Bionime Corporation

Short Term Long Term Short Term Comparison Long Term Comparison

4737
1d-0.43%
1w-0.43%
1m-1.98%
1y-9.16%
4737
1y-9.16%
5y51.26%
10y-4.55%
20y0.00%

Bitcoin
-0.82%
-9.09%
-6.40%
106.24%
Bitcoin
106.24%
1,146.32%
11,770.30%
0.00%

Ethereum
-0.90%
-11.75%
-14.49%
45.57%
Ethereum
45.57%
1,828.08%
0.00%
0.00%

Gold
0.26%
2.56%
11.41%
20.52%
Gold
20.52%
88.92%
85.82%
499.35%

Silver
0.47%
4.25%
15.38%
14.30%
Silver
14.30%
94.94%
48.08%
306.93%

Apple
-2.19%
1.78%
0.04%
5.09%
Apple
5.09%
260.11%
-66.73%
39,041.00%

Amazon
-1.68%
-1.44%
4.92%
78.52%
Amazon
78.52%
96.45%
-43.46%
7,943.96%

Microsoft
-1.96%
-2.97%
-0.67%
45.75%
Microsoft
45.75%
259.81%
923.86%
2,532.12%

S&P 500
-1.20%
-2.84%
-1.08%
22.34%
S&P 500
22.34%
74.12%
171.80%
346.13%

Dow & Jones
-0.65%
-2.95%
-2.53%
11.36%
Dow & Jones
11.36%
42.65%
129.74%
261.03%

ATH

ATH Price$91.20
ATH Date2022-08-30
% since ATH-23.90%
% to ATH31.41%

ATL

ATL Price$32.18
ATL Date2015-02-11
% from ATL115.69%
Last Low Price$68
Last Low Date2024-01-17
% From Last Low2.06%

IPO

IPO Price$65.10
% Current ROI USD106.60%
ATH Price$91.20
% ROI ATH 28,344.81%

[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="4737"]

Key Data [addtoany]

Current price	$69.4
Sector	Healthcare
Industry	Medical Instruments & Supplies
Today's High/Low	$70/$69.4
Volume	13,239.00
Previous Close	$69.7
52 Week High/Low	$90.1/$67.2
Market Cap	4,239,153,920.00
P/E Ratio	697
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$0
Annualized Dividend	$0.0301

$69.4

[addtoany]

Bionime Corporation manufactures and sells medical instruments in Algeria, the United States, Switzerland, China, and internationally.
It offers medical testing blood glucose management products for self-monitor and hospital/clinic use, as well as accessories, such as test strips and lancing devices.
The company was founded in 2003 and is headquartered in Taichung, Taiwan.

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31
Cash on hand	-	-	-	-	-	-	-	-	-	-	-
Receivables	$743.72	$817.05	$597.99	$411.28	$339.16	$325.18	$337.16	$300.97	$286.08	$305.15	$205.26
Inventory	$395.44	$412.42	$364.39	$310.87	$347.49	$327.18	$310.74	$289.92	$321.39	$160.37	$120.78
Pre-Paid Expenses	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	$14.69	$18.59	$16	$19.35	$26.34	$24.02	$121.48	$96.08	$27.30	$76.48	$14.25
Total Current Assets	$1,595.43	$1,769.95	$1,489.28	$1,745.88	$1,541.77	$1,541.88	$1,431.64	-	-	-	-
Property, Plant, And Equipment	$2,676.28	$2,689.67	$2,707.10	$2,729.69	$2,842.72	$2,840.58	$2,887.70	$2,608.38	$1,688.84	$186.61	$115.76
Long-Term Investments	$36.10	$30.10	$30.10	-	-	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	-	-	-	-	-	-	-	-	-
Other Long-Term Assets	$82.14	$91.14	$136.68	$154.40	$156.97	$252.47	$164.31	$50.87	$21.51	$26.60	$49.47
Total Long-Term Assets	$2,808.81	$2,819.46	$2,885.64	$2,900.65	-	-	-	-	-	-	-
Total Assets	$4,404.24	$4,589.40	$4,374.92	$4,646.53	$4,567.24	$4,667.10	$4,524.24	$3,632.18	$2,850.98	$1,287.06	$892.09
Total Current Liabilities	$1,380.97	$1,481.42	$1,559.29	$1,264.29	$691.87	$1,606.81	$1,307.77	$707.33	$664.68	$265.40	$223.23
Long Term Debt	$972.13	$1,114.51	$737.58	$794.71	$1,330.15	$1,710	$2,143.94	$1,923.49	$1,100	-	-
Other Non-Current Liabilities	$0.11	$0.36	$0.45	$0.72	$3.35	$1.39	$1.36	$0.39	$1.22	$5.24	$27.96
Total Long Term Liabilities	$976.43	$1,114.87	$738.03	$795.43	-	-	-	-	-	-	-
Total Liabilities	$2,357.40	$2,596.30	$2,297.31	$2,059.72	$2,025.36	$3,319.93	$3,453.57	$2,631.21	$1,765.90	$270.64	$251.19
Common Stock Net	$596.70	$594.47	$594.47	$634.47	$634.47	$514.47	$439.47	$439.47	$439.47	$399.52	$352.36
Retained Earnings (Accumulated Deficit)	$216.59	$225.51	$97.77	$257.89	$167.42	$117.15	$141.50	$37.61	$179.58	$142.01	$135.44
Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-
Other Share Holders Equity	$30.30	$-5.50	$-8.59	$0.65	$8.11	$5.96	$0.69	-	-	-	-
Share Holder Equity	$2,042.58	$1,991.24	$2,077.60	$2,586.82	$2,541.88	$1,347.17	$1,070.68	$1,000.97	$1,085.08	$1,016.42	$640.90
Total Liabilities And Share Holders Equity	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31
Revenue	$2,172.92	$2,007.22	$1,820.27	$1,740.31	$1,609.72	$1,524.67	$1,560.90	$1,435.02	$1,476.54	$1,211.74	$937.75
Cost Of Goods Sold	$1,224.51	$1,090.22	$1,024.49	$969.82	$908.43	$782.50	$827.76	$708.72	$693.53	$569.82	$453.96
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Research And Development Expenses	$255.12	$201.19	$159.96	$140.39	$117.78	$92	$101.20	$100.04	$100.11	$63.39	$46.02
SG&A Expenses	$526.85	$476.52	$387.40	$371.70	$393.73	$353.31	$381.72	$455.31	$417.54	$334.06	$258.11
Other Operating Income Or Expenses	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	$2,006.48	$1,767.92	$1,571.85	$1,481.91	$1,419.93	$1,375.36	$1,416.02	-	-	-	-
Operating Income	$166.45	$239.30	$248.42	$258.40	$189.78	$149.31	$144.88	$70.87	$193.58	$200.33	$150.15
Total Non-Operating Income/Expense	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	$134.57	$161.96	$188.80	$213.93	$123.23	$85.89	$124.08	$65.40	$215.56	$161.28	$156.20
Income Taxes	$27.86	$34.07	$39.85	$35.14	$24.44	$31.58	$34.15	$31.25	$36.45	$25.23	$20.96
Income After Taxes	$27.86	$34.07	$39.85	$35.14	$24.44	$31.58	$34.15	$31.25	$36.45	$25.23	$20.96
Other Income	-	-	-	-	-	-	-	-	-	-	-
Income From Continuous Operations	$106.71	$127.89	$149.61	$178.79	$98.79	$54.31	$89.93	-	-	-	-
Income From Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-
Net Income	$106.26	$128.03	$149.61	$178.79	$98.79	$54.31	$89.93	$34.15	$179.11	$136.05	$135.24
EBITDA	-	-	-	-	-	-	-	-	-	-	-
EBIT	$166.45	$239.30	$248.42	$258.40	$189.78	$149.31	$144.88	$70.87	$193.58	$200.33	$150.15
Basic Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-
Basic EPS	-	-	-	-	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31
Net Income/Loss	$106.26	$128.03	$149.61	$178.79	$98.79	$54.31	$89.93	$34.15	$179.11	$136.05	$135.24
Total Depreciation And Amortization - Cash Flow	$164.49	$151.34	$145.80	$158.01	$147.80	$141.33	$99.74	-	-	-	-
Change In Accounts Receivable	$63.17	$-217.83	$-113.70	$-79.70	$-12.17	$-15400000	$-7.20	-	$18.89	-	-
Change In Inventories	$16.06	$-49.95	$-53.53	$36.62	$-20.30	$-16.45	$-20.82	$7.84	-	-	-
Cash Flow From Operating Activities	$405.56	$121.90	$29.60	$457.84	$200.37	$359.84	$128.98	$23.58	$216.93	$13.66	$207.56
Cash Flow From Investing Activities	$-129.09	$110.40	$-65.73	$-414.95	$-159.45	$-55.57	$-474.49	-	-	-	-
Debt Issuance/Retirement Net - Total	$-277.18	$256.33	$303.02	$-134.33	$-1,185.64	$-312.60	$804.11	-	-	-	-
Total Common And Preferred Stock Dividends Paid	$-114.89	$-237.83	$-241.10	$-126.89	$-48.36	$-78.23	$-35.16	$-158.21	$-119.86	$-115.95	$-8.37
Financial Activities - Other	$2	$2.05	$2.05	$-0.16	$0.15	$0.01	$0.01	-	-	$364.32	$2.23
Cash Flow From Financial Activities	$-338.02	$20.55	$-361.80	$-261.39	$-93.85	$-107.81	$768.95	$837.93	$1,273.69	$248.37	-
Net Cash Flow	$-74.07	$259.28	$-414.53	$-227.40	$-49.23	$203.24	$430.35	-	-	-	-
Common Stock Dividends Paid	$-114.89	$-237.83	$-241.10	$-126.89	$-48.36	$-78.23	$-35.16	$-158.21	$-119.86	$-115.95	$-8.37